Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group
24/7 Wall St. lists Thursday analyst calls. JPMorgan upgraded Charles River Laboratories (CRL) to Overweight, target $310. Wolfe raised Global Payments (GPN) to Outperform, target $110. Argus upgraded Roper Technologies (ROP) to Buy, target $450. Piper cut AppLovin (APP) to Neutral, target $385, and HubSpot (HUBS) to Neutral, target $220. Several other upgrades, downgrades, and initiations are noted.
How this was made
The 30-second read
Why it matters
For traders, the actionable element is the direction and magnitude of rating and target changes, which can drive short-term positioning and relative performance even without new company fundamentals.
Market read
Multiple single-name rating changes with explicit target resets create near-term trading catalysts, but the article lacks new fundamental disclosures beyond the analyst actions.
What to watch
The article provides no underlying thesis details, so traders should verify whether the rating change reflects new information or just model/assumption updates.
Background
The piece is a daily roundup of analyst upgrades, downgrades, and initiation notes published for Thursday, Aug 6, 2026.
Ticker impact
JPMorgan upgraded Charles River Laboratories to Overweight from Neutral and raised its target to $310 from $180.
Mild-to-moderate upside bias into the next few sessions, especially if broader biotech/life-science sentiment is stable.
The article discloses a fresh rating change plus a substantial target reset, which often drives short-term flows even without new fundamentals.
Wolfe Research raised Global Payments to Outperform from Peer Perform and set a $110 target.
Potential upside drift as traders price in the new consensus view.
The text provides a specific upgrade and target, a concrete catalyst for positioning.
Argus upgraded Roper Technologies to Buy from Hold and set a $450 target.
Moderate upside bias, particularly if the market is risk-on.
A clear change in analyst stance and target level is actionable for short-term trading.
Raymond James upgraded Sabra Health Care REIT to Market Perform from Underperform, with no price target.
Slight upside or reduced volatility versus prior positioning.
The article confirms an upgrade but provides no target, reducing the strength of the signal.
Piper Sandler cut AppLovin to Neutral from Overweight and lowered its target to $385 from $665.
Downside bias or underperformance risk over the next few sessions.
The disclosed target reduction is large and can quickly change trader expectations even without new company news.
Piper Sandler cut HubSpot to Neutral from Overweight and lowered its target to $220 from $250.
Mild-to-moderate downside bias, especially if growth stocks are sensitive to guidance expectations.
The article provides a specific downgrade and target trim, a direct sentiment catalyst.
Wells Fargo downgraded Insulet to Equal Weight from Overweight and cut its target to $144 from $255.
Higher probability of near-term underperformance versus the broader market.
The magnitude of the target reduction is substantial, which typically matters for trading flows.
Summit Insights downgraded Western Digital to Hold from Buy, with no price target.
Limited downside bias, more likely to cap rallies than drive a sharp move.
The article confirms a rating change but lacks a target or other quantitative catalyst.
Market effects
Broad set of analyst rating changes across biotech, payments, software, medtech, and housing-related names may shift relative performance within growth and healthcare baskets.
Primarily US-listed equities; limited direct cross-region impact implied.
Low, as the disclosed catalysts are company-specific analyst actions rather than global macro shocks.
Counterpoint
Analyst target changes can fade quickly if they are not backed by new earnings, trial, or guidance data.
Key entities
- media247wallst.com
Publisher of the analyst-call roundup.
- analyst_firmJPMorgan
Upgraded CRL and set a higher target.
- analyst_firmPiper Sandler
Downgraded APP and HUBS with lower targets.
- analyst_firmWells Fargo
Upgraded NWN and downgraded PODD.
- analyst_firmBernstein
Downgraded ZG and cut its target.
